ICON Biotech surveyed 163 biotech leaders in North America, EMEA and APAC to see how they are responding to the headwinds.
Deepali Suri
Advertisement
Deepali Suri is president at ICON Biotech.
Articles by Deepali Suri
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Grants Priority Review to Enhertu as Treatment for Patients with HER2-positive Early Breast Cancer
2
AI has Redefined Healthcare Communication — and There’s No Opting Out
3
How FDA's Removal of the Two-Trial Requirement Affects Development Programs
4
Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals
5